Atom | Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Funding Amounts: No funds awarded directly; provides access to preclinical research services for up to 1-2 years depending on service type.

Summary: Provides investigators access to preclinical services to support development of therapeutics for HIV and HIV-associated co-infections including HBV, HCV, and Tuberculosis.

Key Information: Clinical trials are not allowed; multiple service areas require separate applications; foreign institutions eligible; applications must comply with NIH submission requirements.

Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

Sign in to see full grant listing